CGAU vs EGO: Which Is the Better Buy in 2026?
Last updated October 2026
Short answer
EGO is the larger of the two ($9.37B market cap): the incumbent the market prices for continued execution (7.11x forward earnings, beta 1.51). CGAU is the smaller challenger ($4.38B), actually pricier on forward earnings (10.93x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
CGAU vs EGO: the tie-breaker metrics
Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | CGAU | EGO | What it tells you |
|---|---|---|---|
| Market cap | $4.38B | $9.37B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 10.93 | 7.11 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 7.00 | 12.52 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 1.60 | 1.51 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 82% of range | 43% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 2.00 | 1.37 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: EGO is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how CGAU and EGO affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CGAU and EGO share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CGAU and EGO exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Centerra Gold (CGAU) do?
Centerra Gold is a Canada-based mid-tier mining company that produces gold, copper, and molybdenum. Its gold and copper output comes mainly from two operating mines: the Mount Milligan gold-copper mine in British Columbia, Canada, and the Oksut gold mine in Turkey. Alongside these, Centerra owns a Molybdenum Business Unit in the United States and Canada, which includes the Langeloth processing facility and the Thompson Creek mine that is being restarted, plus the Kemess gold-copper development project in British Columbia. Because gold, copper, and molybdenum are globally priced commodities, Centerra is largely a price-taker: its revenue tracks metal prices while a large share of its mining costs are relatively fixed, which creates operating leverage that can push profits up faster than the gold price in a strong market and down faster in a weak one.
What does Eldorado Gold Corp (EGO) do?
Eldorado Gold Corp (NYSE and TSX: EGO) is a Vancouver-based mid-tier precious-metals producer with four operating mines: Kisladag and Efemcukuru in Turkey, the Lamaque Complex in Quebec, Canada, and Olympias in Greece. In the first quarter of 2026 the company produced roughly 100,000 ounces of gold and reported about $532 million in revenue, helped by an average realized gold price near $4,900 per ounce. Management guides to 490,000 to 590,000 ounces of gold in 2026 at total cash costs of roughly $1,220 to $1,420 per ounce, with output weighted to the second half of the year.
CGAU vs EGO: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- CGAU drivers: Leverage to a strong gold and copper market; Strong balance sheet and shareholder returns.
- EGO drivers: Skouries ramp-up; Copper diversification via Foran / McIlvenna Bay.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The dominant risk is metal prices, especially gold: as a commodity producer, Centerra's profits rise and fall with the market, and its operating leverage magnifies moves in both directions. For EGO, eldorado carries meaningful execution risk on two large capital projects ramping at once, and Skouries first concentrate already arrived about a quarter later than first guided.
CGAU or EGO: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CGAU if you believe its drivers more; EGO if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CGAU and EGO guides.
CGAU vs EGO: the full fundamentals
CGAU. At $22.15 on October 16, 2026, Centerra trades near 7 times trailing earnings but about 11.7 times forward estimates, because trailing net income includes unusually large late-2025 quarters and consensus expects 2027 EPS of about $1.89. Roughly 2 times book value and 4.5 times EV/EBITDA still look modest for a near debt-free producer, but those multiples rest on peak-cycle gold and copper margins and on capital spending that held trailing free cash flow close to zero. The October 29 third-quarter report will show how much of the price strength is reaching cash flow while Thompson Creek, Goldfield and Kemess absorb capital.
EGO. Eldorado trades near $36.59 for a market cap around $9.5 billion, about 12.8x trailing and 7x forward earnings. The gap between those two multiples is the Skouries and McIlvenna Bay ramp: consensus has EPS rising from about $3.29 in 2026 to about $5.23 in 2027 on revenue near $4 billion. Free cash flow is still negative because of project spending, so the valuation leans on that ramp arriving on schedule and on gold holding up.
Headline figures (approximate, October 2026): CGAU shows revenue (ttm) ~$1.72B; Q2 2026 ~$443M, up ~54% year over year, net earnings ~$637M TTM (includes large 2025 quarters); Q2 2026 ~$72M, q2 2026 adjusted eps ~$0.39 vs ~$0.38 consensus, margins (ttm) Gross ~44%, operating ~27%; EGO shows market cap ~$9.5B (share price ~$36.59), revenue (ttm) ~$2.03B (up ~8% YoY in latest quarter), q2 2026 revenue / adjusted eps ~$487M / $0.54 (est. ~$0.57), net income (ttm) ~$618M (~30% net margin).
The bottom line: CGAU vs EGO
CGAU and EGO are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CGAU and EGO exposure against your real portfolio. It is not an investment adviser.
Wondering how CGAU or EGO fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Centerra Gold with AI
Connect the broker you already use and ask Walnut's AI how CGAU fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between CGAU and EGO?
+
Centerra Gold is a Canada-based mid-tier mining company that produces gold, copper, and molybdenum. Eldorado Gold Corp (NYSE and TSX: EGO) is a Vancouver-based mid-tier precious-metals producer with four operating mines: Kisladag and Efemcukuru in Turkey, the Lamaque Complex in Quebec, Canada, and Olympias in Greece. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is CGAU or EGO the better stock?
+
Neither is universally better. EGO is the larger incumbent; CGAU is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, CGAU or EGO?
+
On forward P/E (as of October 2026), CGAU trades at 10.93x and EGO at 7.11x, so EGO is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both CGAU and EGO?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of CGAU vs EGO?
+
CGAU: The dominant risk is metal prices, especially gold: as a commodity producer, Centerra's profits rise and fall with the market, and its operating leverage magnifies moves in both directions. Concentration is a second major risk, because gold and copper output leans heavily on just two mines (Mount Milligan and Oksut), so a problem at either can swing companywide results. Jurisdiction adds risk, since Oksut operates in Turkey, which carries greater political, currency, and regulatory uncertainty than the Canadian and US assets, and Centerra has previously navigated a major dispute over its former Kumtor mine in the Kyrgyz Republic. Execution risk is real on the Thompson Creek restart and Kemess, where cost overruns, permitting delays, or weak molybdenum prices could erode returns, and the molybdenum unit has already shown operational interruptions. Finally, cost inflation, reserve replacement, and the finite life of mines mean every ounce produced must eventually be replaced through exploration or development. After a roughly 57% gain in 2026, the share price also embeds high metal prices: consensus expects EPS to slip from about $0.39 in the second quarter to $0.33 in the third and $0.34 in the fourth, and trailing free cash flow was close to zero as capital spending rose across three development projects. EGO: Eldorado carries meaningful execution risk on two large capital projects ramping at once, and Skouries first concentrate already arrived about a quarter later than first guided. Heavy capital spending has kept trailing free cash flow at about minus $454 million and pushed total debt to around $1.76 billion, against about $555 million of cash. The company operates in Turkey and Greece, which add geopolitical, permitting, and currency risk, and the Foran deal introduces integration risk plus new copper-price exposure. Above all, the stock is highly sensitive to the gold price: it fell about 15% in the month to October 16, 2026 and sits well below its 52-week high near $51, a reminder that a gold pullback hits the shares hard.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CGAU or EGO; figures are approximate and dated (as of October 2026). Verify current data before investing.